The Environmental Protection Agency identifies dozens of pesticide active ingredients as likely or possible carcinogens, yet a very small share of the products containing those ingredients carry cancer warnings on their labels. That disconnect sits at the center of a growing legal and regulatory debate over whether the federal government is doing enough to alert consumers, farmworkers, and homeowners to potential health risks. New analyses from advocacy groups, combined with the agency’s own policy documents, reveal a system in which flagging a cancer risk and actually telling the public about it are two very different steps.
How EPA Flags Cancer Risk but Stops Short of Warnings
EPA’s Office of Pesticide Programs evaluates whether an active ingredient may cause cancer through a process that weighs animal studies, epidemiological data, and real-world exposure patterns. The agency’s cancer review framework applies a weight-of-evidence system that can classify chemicals as “likely to be carcinogenic to humans” or “suggestive of carcinogenic potential,” among other categories. Those classifications feed into risk assessments that shape how a pesticide may be used, but they do not automatically trigger label language telling buyers about the finding.
The reason lies in how label changes work. Under the agency’s labeling guidance, every new or changed statement must go through EPA review and approval. The policy distinguishes between mandatory statements, which registrants must include, and advisory statements, which they may add voluntarily. Adding an explicit cancer warning falls squarely into the category of changes that require the agency’s sign-off. Because the process is discretionary rather than automatic, a cancer classification can sit in EPA’s scientific files for years without ever reaching the product packaging a consumer reads at a hardware store.
In practice, registrants rarely seek to add language that could suggest their product is unsafe, and EPA has not established a default rule that would require such warnings whenever its scientists identify carcinogenic potential. Instead, the agency tends to address cancer concerns through use restrictions, protective equipment requirements, or application limits, while leaving the word “cancer” off the front-facing label. That approach keeps labels from becoming crowded or alarming, but it also means the most serious hazard information is often buried in technical documents the public never sees.
Glyphosate: The Case That Sharpened the Conflict
No pesticide better illustrates this tension than glyphosate, the active ingredient in Roundup. After the International Agency for Research on Cancer classified glyphosate as “probably carcinogenic to humans” in 2015, California added it to the state’s Proposition 65 list, requiring cancer warnings on products sold there. EPA took the opposite position. The agency concluded that glyphosate does not pose a cancer risk to people when used according to label directions, and it moved to block cancer language on glyphosate products in California, calling such warnings inaccurate and misleading.
That decision did more than settle a labeling dispute. It signaled that EPA would not only decline to require cancer warnings in certain cases but would actively prevent them from appearing. The agency framed its intervention as consumer protection, arguing that false or misleading statements on pesticide labels could confuse the public and undermine confidence in the regulatory system. Critics countered that the agency was substituting its own risk conclusion for a precautionary message that would let people make informed choices, especially when an international body had reached a different view of the underlying science.
The glyphosate controversy also underscored how little room states and localities may have to depart from EPA’s judgments. If a state wants to err on the side of caution by demanding stronger warnings, the federal government can step in and say that doing so would conflict with the uniform national labeling scheme Congress established for pesticides. That conflict is now playing out in the courts.
Federal Preemption and the Supreme Court
The glyphosate fight has since moved to the highest court in the country. In Monsanto Co. v. Durnell, the U.S. Supreme Court is weighing whether the Federal Insecticide, Fungicide, and Rodenticide Act and EPA’s labeling authority preempt state-law failure-to-warn claims tied to alleged cancer risks from Roundup. The Solicitor General’s brief argues that federal law should take precedence, a position that, if adopted, would sharply limit the ability of individuals to sue manufacturers for not disclosing cancer risks that EPA chose not to require on labels.
The stakes extend well beyond one herbicide. If the Court sides with federal preemption, the practical effect would be to make EPA the sole gatekeeper for cancer-related label language on all registered pesticides. Consumers and workers who believe a product harmed them would lose a key legal avenue for holding manufacturers accountable in state courts. The outcome could reshape liability across the entire pesticide industry, tying public health information almost entirely to the agency’s own willingness to act.
On the other hand, if the Court allows state failure-to-warn suits to proceed, manufacturers could face a patchwork of jury verdicts and settlement pressures that push them to add warnings even when EPA has not required them. That scenario would give injured plaintiffs a path to compensation and might spur more precautionary labeling, but it could also erode the uniformity that federal regulators and industry say is essential for national markets.
Label Database Reveals a Persistent Gap
Recent analyses from the Center for Food Safety and the Center for Biological Diversity examined EPA’s own records and found that a very low share of products carry cancer warnings even when the agency has designated the active ingredient as a likely or possible carcinogen. The groups drew on the Pesticide Product Label System, a publicly accessible EPA database that houses the official, stamped labels for registered products. Anyone can search that system by registration number and pull the exact label language EPA has approved.
The pattern the groups documented is straightforward: EPA’s scientists classify a chemical as potentially cancer-causing, the risk assessment enters the agency’s files, and the label the consumer sees says nothing about it. That gap is not a bug in the system. It is a feature of a regulatory design that treats cancer warnings as discretionary add-ons rather than automatic consequences of the agency’s own scientific findings. The result is that people spraying pesticides in their yards or working in agricultural fields may never learn that the product they are handling contains an ingredient EPA itself has flagged.
Advocates say the label database offers a rare window into how those decisions play out in practice. By comparing scientific classifications with on-the-ground labels, they argue, it becomes clear that the default outcome is silence on cancer, not disclosure. The analyses have fueled calls for EPA to adopt a more transparent, rule-based approach that would tie specific label statements to its carcinogenicity categories.
Why the Labeling System Works This Way
EPA’s approach reflects a distinction between hazard identification and risk characterization that runs through federal chemical regulation. Hazard identification asks whether a substance can cause cancer under any conditions. Risk characterization asks whether it will cause cancer at the doses and exposure levels people actually encounter. EPA has long argued that labeling decisions should reflect the second question, not the first, meaning that a substance can be recognized as capable of causing tumors in laboratory settings without being labeled as a cancer risk for everyday users.
Agency officials also point to competing demands on the pesticide label itself. Labels must communicate directions for use, safety precautions, environmental warnings, and legal restrictions in a limited space. Adding cancer language for dozens of products, they contend, could dilute attention from immediate hazards like acute poisoning or eye damage. Yet for farmworker advocates and environmental health groups, this reasoning places too much weight on avoiding alarm and not enough on giving people the information they need to decide whether to apply a product at all.
Some critics have turned to other levers of federal power, urging the administration to push EPA toward stronger disclosure. They note that the executive branch, through policy priorities outlined on the White House website, can signal how aggressively agencies should act on environmental health risks. Others have encouraged the public to make use of enforcement tools, including EPA’s online portal where people can report potential violations of environmental laws, when they suspect pesticides are being used in ways that increase cancer risks beyond what labels contemplate.
Pressure for Reform
As the Supreme Court weighs preemption and advocacy groups spotlight the disconnect between science and labels, pressure is mounting for EPA to reconsider how it handles cancer information. One option would be to adopt a bright-line rule: whenever an active ingredient is classified as “likely” or “suggestive” for carcinogenicity, the label would have to include a standardized cancer statement. Another would be to create a tiered system of warnings, with clearer language for products that pose higher lifetime risks under realistic exposure scenarios.
Industry groups warn that such changes could stigmatize useful pest-control tools and drive users toward unregulated alternatives. Public health advocates respond that transparency is a prerequisite for trust and that hiding cancer findings in technical documents undermines the very confidence regulators say they want to preserve. With legal, scientific, and political pressures converging, the question is no longer whether EPA can keep cancer classifications off pesticide labels, but how long it can defend a system in which most people never see the warnings its own scientists imply.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
